Showing results (371-380 of 1,086) with videos related to
Sort By:
Pageof 109
Journal of Cardiovascular Translational Research|December 21, 2013
Impact of cigarette smoking on P2Y12 receptor binding activity before and after clopidogrel therapy in patients with coronary artery diseaseJung Rae Cho, Bhaloo Desai, Michael J Haas, et al.Journal of the American College of Cardiology|January 17, 2017
Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes MellitusDeepak L Bhatt, Tilo Grosser, Jing-Fei Dong, et al.European Heart Journal|January 22, 2011
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialDominick J Angiolillo, Juan Jose Badimon, Jorge F Saucedo, et al.European Heart Journal. Cardiovascular Pharmacotherapy|May 16, 2024
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysisMattia Galli, Giovanni Occhipinti, Stefano Benenati, et al.Nature Reviews. Cardiology|August 24, 2021
Bleeding avoidance strategies in percutaneous coronary interventionDavide Capodanno, Deepak L Bhatt, C Michael Gibson, et al.Journal of the American Heart Association|February 8, 2022
ABCD-GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR-PCI TrialDavide Capodanno, Dominick J Angiolillo, Ryan J Lennon, et al.European Heart Journal|August 31, 2010
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trialStefan James, Dominick J Angiolillo, Jan H Cornel, et al.Journal of Thrombosis and Thrombolysis|August 18, 2014
Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonistsFrancesco Franchi, Jafri Syed Hammad, Fabiana Rollini, et al.Circulation|August 26, 2016
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 StudyFrancesco Franchi, Fabiana Rollini, Niti Aggarwal, et al.Thrombosis and Haemostasis|September 18, 2024
Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER Using the PASCAL SystemMiriam Euper, Jürgen Schreieck, Mareike Bladt, et al.Pageof 109